TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
AGEN

Agenus Inc

Healthcare · Biotechnology

8.70$ +4.4% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Agenus Inc (AGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 173 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AGEN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
335 314 257 292 238 226 200 185 234 227 186 173
126 112 60 100 50 46 23 13 134 133 95 79
106 76 53 94 45 40 18 9.5 3.5 3.0 35 19
106 76 53 94 45 40 18 9.5 3.5 3.0 35 19
1.0 26 0.5 0.7 0.2 0.4 0.4 0.7 6.3 1.8 54 15
16 0.0 0.0
25 25 25 25 25 24 24 24 24 24 24 24
4.5 4.4 4.2 4.1 4.0 3.4 3.3 3.2 3.1 3.0 3.0 2.9
451 462 447 513 510 533 523 522 515 505 414 379
198 256 256 271 271 221 208 235 287 323 249 232
13 146 161 25 183 9.8 5.2 14 12 155 141 31
41 61 51 51 46 61 64 74 85 83 71 59
13 13 30 33 23 24
-129 -160 -201 -241 -292 -326 -342 -355 -274 -271 -221 -199
-1,909 -1,956 -2,018 -2,071 -2,137 -2,183 -2,208 -2,236 -2,172 -2,183 -2,144 -2,144
19 20 20 21 22 23 24 28 33 35 38 41

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?